Topical corticosteroids are among the most effective treatments for inflammatory skin diseases, but some patients experience worsening skin after stopping them. Whether this represents topical steroid withdrawal (TSW), steroid rebound, recurrence of eczema, rosacea, perioral dermatitis, or another inflammatory skin disease, the skin barrier is usually severely compromised. Because the treatment goals are remarkably similar regardless of the exact diagnosis, restoring the skin barrier should be the foundation of recovery. This article explains the science behind topical steroid withdrawal and how to choose skincare products that help repair the skin while reducing inflammation and irritation.

If you've ever stopped a medication and had the original problem return, you've experienced what doctors call rebound. Rebound can occur because:

• the underlying disease becomes active again after treatment stops
• the medication itself causes rebound symptoms
• you develop an allergy to the medication or another ingredient in the product. 

A familiar example of true medication caused rebound is with oxymetazoline found in Afrin® nasal spray, which can cause rebound congestion after prolonged use (In the  nose- this does not occur in the skin). 

Another example is "ChapStick addiction," in which frequent use of occlusive lip balms can create a cycle of repeated application because the lips feel drier when the product wears off. 

Topical corticosteroids are more complex because worsening skin after stopping treatment may represent topical steroid withdrawal (TSW), steroid rebound, recurrence of the underlying skin disease, or allergic contact dermatitis. Regardless of the cause of TSW, repairing the skin barrier is one of the most important steps toward recovery.

Topical steroid withdrawal (TSW), also called topical corticosteroid withdrawal, red skin syndrome, or topical steroid addiction, is a condition in which the skin becomes red, inflamed, painful, or intensely itchy after topical corticosteroids are discontinued. In some patients, the rash extends beyond the areas where topical steroids were originally applied.

Although TSW is increasingly recognized by dermatologists and regulatory agencies, there are still no universally accepted diagnostic criteria, and its prevalence remains unknown. 

 After stopping topical steroids, worsening skin may be caused by topical steroid withdrawal (TSW), steroid rebound, recurrence of the underlying skin disease, allergic contact dermatitis, or skin infection. Because these conditions often overlap, determining the exact cause can be difficult. Fortunately, the initial treatment is similar: repair the skin barrier, reduce inflammation, avoid allergens and irritants, and treat the underlying skin disease when appropriate.

Many dermatologists believe that symptoms attributed to TSW often represent recurrence of the underlying skin disease, steroid misuse, or another condition such as allergic contact dermatitis rather than steroid withdrawal. (Hajar T. JAAD 2015)

Millions of people online believe TSW is a distinct clinical entity that occurs in susceptible individuals after prolonged topical steroid use. There are many discussions about TSW on Reddit. Additional research is needed to better define the condition, it's causes, and identify those at greatest risk.

Regardless of whether inflammation is caused by topical steroid withdrawal, steroid rebound, eczema, rosacea, perioral dermatitis, or allergic contact dermatitis, inflammation damages the skin barrier—and a damaged skin barrier allows even more inflammation to occur. Breaking this cycle is essential for recovery.
One of the biggest misconceptions about topical steroid withdrawal is that any moisturizer will help the skin recover. While most moisturizers temporarily relieve dryness, only barrier repair moisturizers are designed to restore the skin's natural protective barrier. This distinction is important because repairing the skin barrier reduces transepidermal water loss (TEWL), calms inflammation, accelerates healing, and helps protect the skin from allergens, irritants, bacteria, and environmental irritants.
Barrier repair involves more than choosing the right moisturizer. It also requires using a barrier-safe cleanser that removes dirt, sweat, and excess oil without stripping away the protective lipids that help keep the skin healthy. Harsh soaps and foaming cleansers can further damage an already compromised skin barrier, increasing dryness, irritation, and inflammation. Instead, choose a fragrance-free cleanser formulated with gentle surfactants. These cleansers are often creamy or lotion-based rather than heavily foaming and cleanse the skin without leaving it feeling tight or dry.

The skin barrier is located in the stratum corneum, the outermost layer of the epidermis. It consists of skin cells called corneocytes that are surrounded by multiple lipid bilayer membranes. Between adjacent corneocytes are extracellular lamellar lipids composed primarily of ceramides, cholesterol, and free fatty acids. Together, these lipid bilayers create an almost continuous waterproof seal that keeps moisture inside the skin while preventing allergens, irritants, microbes, and pollutants from entering.
The strength and integrity of the skin barrier depends on both the composition and the three-dimensional organization of these lipids. 

In healthy skin, the lipid bilayers are arranged into highly ordered lamellar membranes. Within these membranes, the lipids adopt an orthorhombic packing arrangement, the most tightly packed lipid organization found in human skin. Because the lipids are packed so closely together, there is very little space for water to escape or for irritants to penetrate. This highly organized structure is responsible for the remarkable barrier properties of healthy skin. Inflammation disrupts this lipid pattern resulting in a compromised skin barrier that is not as protective.

For patients recovering from topical steroid withdrawal, rebuilding this highly organized lipid barrier in the orthorhombic pattern is one of the most important steps toward reducing transepidermal water loss, calming inflammation, and restoring healthy skin.

A true barrier repair moisturizer does more than simply add moisture or supply ceramides. They must have a 1:1:1 ratio of fatty acids, ceramides and cholesterol. An effective moisturizer to treat TSW must be formulated so that the physiologic skin lipids can self-assemble into organized lamellar liquid crystal structures that mimic the architecture of the normal stratum corneum. 

One way to evaluate how good a moisturizer is at repairing the skin barrier is with cross-polarized light microscopy. Moisturizers that form organized lamellar liquid crystal structures display a characteristic Maltese cross pattern. The Maltese cross indicates that the lipids have aligned into an ordered three-dimensional structure similar to the natural orthorhombic organization of healthy skin. This organization allows the moisturizer to integrate into the damaged skin barrier, develop the tight orthorhombic pattern, and restore barrier function.

[[ctaquiz]]

1. Goldenberg A, Jacob S, Contact Dermatitis (Type 4 Sensitive Skin) in Ch. 19 of Baumann's Cosmetic Dermatology Ed 3. (McGraw Hill 2022)
2. Baumann, L. Anti-inflammatory Ingredients in Ch.64-74 Cosmeceuticals and Cosmetic Ingredients (McGraw Hill 2015)
3. Baumann L, Weisburg E. Anti-inflammatory Ingredients in Ch. 38 of Baumann's Cosmetic Dermatology Ed 3. (McGraw Hill 2022)
4. Brookes TS, Barlow R, Mohandas P, Bewley A. Topical steroid withdrawal: an emerging clinical problem. Clin Exp Dermatol. 2023;48(9):1007-1011.
5. Sheary B. Steroid withdrawal effects following long-term topical corticosteroid use. Dermatitis. 2018;29(4):213-218.
6. Tan SY, Chandran NS, Choi EC. Steroid phobia: Is there a basis? A review of topical steroid safety, addiction and withdrawal. Clin Drug Investig. 2021;41(10):835-842.
7. Marshall HF, Leung DYM, Lack G, et al. Topical steroid withdrawal and atopic dermatitis. Ann Allergy Asthma Immunol. 2024;132(4):423-425.
8. Hajar T, Leshem YA, Hanifin JM, Nedorost ST, Lio PA, Paller AS. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015;72(3):541-549.e2.
9. Hwang J, Lio PA. Topical corticosteroid withdrawal: An updated systematic review of diagnostic features, risk factors, and treatment. J Am Acad Dermatol. 2022;86(4):769-779.